Search

The American College Gastroenterology (ACG) recently released the 2024 edition of Guidelines for the management of acute pancreatitis. The guidelines first discuss the diagnosis, etiology, severity, and early management of acute pancreatitis, as well as the management of complications, especially pancreatic necrosis, and then the guidelines propose the clinical decisions such as antibiotics, nutrition, endoscopy, radiology, and surgical intervention. This article makes an excerpt of the key concepts and recommendations in the guidelines. [ABSTRACT FROM AUTHOR]

Copyright of Rigakuryoho Kagaku is the property of International Press Editing Center Incorporation and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Copyright of Chinese Journal of Contemporary Pediatrics is the property of Xiangya Medical Periodical Press and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Copyright of Chinese Journal of Clinical Healthcare is the property of Chinese Journal of Clinical Healthcare and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Diabetic retinopathy (DR) is one of the important complications of diabetes. As a new medical model, “Internet + nursing” has developed rapidly in the field of nursing, providing patients with more convenient and accurate medical services, and playing a vital role in strengthening disease management. This article reviewed the relevant research results in recent years, and analyzed the progress of “Internet + nursing” in the disease management of DR patients, including the implementation of online education, health follow-up, disease risk prediction and screening. The aim was to provide reference for the development of “Internet + nursing” in DR patients and its clinical application. [ABSTRACT FROM AUTHOR]

Copyright of Chinese Journal of Clinical Healthcare is the property of Chinese Journal of Clinical Healthcare and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Copyright of Chinese Journal of Clinical Healthcare is the property of Chinese Journal of Clinical Healthcare and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Copyright of Chinese Journal of Clinical Healthcare is the property of Chinese Journal of Clinical Healthcare and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Copyright of Chinese Journal of Clinical Healthcare is the property of Chinese Journal of Clinical Healthcare and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Copyright of Chinese Journal of Clinical Healthcare is the property of Chinese Journal of Clinical Healthcare and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Inflammatory bowel disease （IBD） is a group of chronic nonspecific intestinal inflammatory diseases with unknown etiology. It has been found that approximately 10%-20% of IBD occurs in old age. At present， the prevalence and quantity of elderly-onset IBD are increasing. The treatment strategy of elderly-onset IBD becomes complicated by physical function， presence of comorbidities and multi-drug interactions， which simultaneously affect the selection of IBD-related drugs. In this article， literature search at home and abroad was conducted from 2017 to 2023， aiming to illustrate the characteristics of elderly-onset IBD from two aspects of treatment and malignant tumor surveillance， and provide reference for clinical practice. [ABSTRACT FROM AUTHOR]

Copyright of Chinese Journal of Clinical Healthcare is the property of Chinese Journal of Clinical Healthcare and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Liver cirrhosis is a major global health burden worldwide due to its high risk of morbidity and mortality. Role of terlipressin for the management of liver cirrhosis related complications has been recognized during recent years. This paper aims to develop evidence-based clinical practice guidance on the use of terlipressin for liver cirrhosis related complications. Hepatobiliary Study Group of Chinese Society of Gastroenterology of Chinese Medical Association and Hepatology Committee of Chinese Research Hospital Association have invited gastroenterologists, hepatologists, infectious disease specialists, surgeons, and clinical pharmacists to formulate the clinical practice guidance based on comprehensive literature review and experts’ clinical experiences. Overall, 10 major statements regarding efficacy and safety of terlipressin in liver cirrhosis were proposed. Terlipressin can be beneficial for the management of cirrhotic patients with acute variceal bleeding and hepatorenal syndrome (HRS). However, the evidence regarding the use of terlipressin in cirrhotic patients with ascites, post-paracentesis circulatory dysfunction, and bacterial infections and in those undergoing hepatic resection and liver transplantation remains insufficient. Terlipressin-related adverse events, mainly including gastrointestinal symptoms, electrolyte disturbance, and cardiovascular and respiratory adverse events, should be closely monitored. The current clinical practice guidance supports the use of terlipressin for gastroesophageal variceal bleeding and HRS in liver cirrhosis. High-quality studies are needed to further clarify its potential effects in other liver cirrhosis related complications. [ABSTRACT FROM AUTHOR]

Postpartum pain is a common problem for pregnant women. Improper treatment may lead to adverse consequences such as greater opioid use, postpartum depression, and development of persistent pain. Therefore, ACOG put forward clinical consensus about the recommendations on pharmacologic stepwise multimodal approach for postpartum pain management in 2021, especially for acute perineal, uterine and incisional pain. In addition, it also provides advices for the treatment of postpartum pain when breastfeeding or discharge, and emphasizes the principle of individualized medication. The recommended clinical medication can follow the step by-step administration of "non-opioid analgesics (such as acetaminophen and non-steroidal anti-inflammatory drugs) - weak opioids - strong opioids (if necessary)". Those can be combined reasonably. We tried to interpreted the main viewpoints of this clinical consensus in this review. [ABSTRACT FROM AUTHOR]

It has been over 60 years since the first global case of pediatric liver transplantation. With continuous refinements of surgical techniques and post-surgical management of pediatric liver transplantation, the number of surgeries is steadily rising while surgical quality is gradually greater. Such developed countries as Europe, USA, Japan and South Korea have enjoyed an early start and accumulated rich experiences of treatment discipline and long-term management of patients and grafts. Pediatric liver transplantation in Chinese mainland began late but has been rapidly developing in recent years. This review summarized the overall development and focused upon key issues of domestic and foreign pediatric liver transplantations. [ABSTRACT FROM AUTHOR]

Copyright of Chinese Journal of Clinical Healthcare is the property of Chinese Journal of Clinical Healthcare and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Copyright of Chinese Journal of Clinical Healthcare is the property of Chinese Journal of Clinical Healthcare and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Objective: To investigate the clinical characteristics and pregnancy outcome of women with traumatic spinal cord injury. Methods: 7 women with spinal cord injury were examined and delivered in Xuanwu Hospital of Capital Medical University from February 2012 to June 2020. We reported the clinical characteristics and analyzed the pregnancy outcome and the management of perinatal period retrospectively. Results: All of 7 women aged 27 to 42 years. The course of disease was 3 ~ 18 years in 6 cases. One case was acute spinal cord injury caused by traffic accident during pregnancy. All 7 cases were spinal cord injury caused by trauma, and the injury level was below T6-T10. There were 5 primipara and 2 multipara patients. EPDS scores ranged from 0 to 17 in first trimester pregnancy, 3 to 27 in the second trimester, 2 to 13 in the third trimester, and 1 to 9 in puerperium. Urinary tract infection was the most common complication during pregnancy, followed by anemia, premature rupture of membrane, fetal growth restriction and gestational diabetes mellitus. The gestational age was 35+3 -39+5 weeks. 2 cases were delivered vaginally, and one of two was delivered by forceps. 5 cases had cesarean section. Apgar score of all babies were 10 points at 1, 5, 10 min, the body weight was 2 350-3 250 g. Puerperal complications including 2 puerperal infection, 1 urinary tract infection and 1 lower limb venous thrombosis, 1 postpartum hemorrhage and 1 pneumonia. Four cases were breast-fed. Conclusions: Patients with spinal cord injury should be evaluated before pregnancy, strengthened monitering during pregnancy and supervised by multidisciplinary team. Prenatal patients should be in hospitalized earlier in order to alert to the occurrence of premature labor, and during delivery, it is of great importance to eliminate the risk of abnormal autonomic reflex. Additonally, the prevention of thrombogenesis and bedsore after delivery is crucial. Whether breastfeeding is suitable depends on the individual condition of the patients. [ABSTRACT FROM AUTHOR]

Copyright of Chinese Journal of Clinical Healthcare is the property of Chinese Journal of Clinical Healthcare and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Copyright of Chinese Journal of Clinical Healthcare is the property of Chinese Journal of Clinical Healthcare and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Copyright of Chinese Journal of Clinical Healthcare is the property of Chinese Journal of Clinical Healthcare and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Copyright of Chinese Journal of Clinical Healthcare is the property of Chinese Journal of Clinical Healthcare and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Liver transplantation is a major treatment for patients with alcoholic liver disease (ALD)-related end-stage cirrhosis, liver failure, hepatocellular carcinoma (HCC) and severe alcoholic hepatitis. In this article, the latest research progress on liver transplantation in ALD patients was summarized from the aspects of surgical indications, survival status, alcohol-drinking management and systemic disease management of the recipients, aiming to provide reference for better clinical management of ALD recipients undergoing liver transplantation. [ABSTRACT FROM AUTHOR]

In recent years, the prevention and treatment of heart failure with preserved ejection fraction (HFpEF) has become a hot spot issue for cardiovascular doctors all over the world. Prevention and treatment of HFpEF is a long-term, integrated process. Although progress has been made in standardizing drug treatment, the symptoms of HFpEF patients are still not well controlled. Therefore, a the whole-cycle health management model based on reasonable prevention and treatment is of great significance for patients with HFpEF. With the deepening of long-termfollow-up management and prognosis research on HFpEF patients, the chronic disease trajectory model has gradually become a standardized management model with good prospects. Scientific and rational management of chronic disease trajectory patterns can better control the symptoms of patients with HFpEF and continuously improve their quality of life. This article reviews the recent advances in chronic disease trajectory management in patients with HFpEF. [ABSTRACT FROM AUTHOR]

Copyright of Chinese Journal of Clinical Healthcare is the property of Chinese Journal of Clinical Healthcare and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Copyright of Chinese Journal of Clinical Healthcare is the property of Chinese Journal of Clinical Healthcare and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Copyright of Chinese Journal of Clinical Healthcare is the property of Chinese Journal of Clinical Healthcare and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Copyright of Chinese Journal of Clinical Healthcare is the property of Chinese Journal of Clinical Healthcare and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

目的 探讨慢性肾脏病管理模式对慢性肾脏病伴高尿酸血症患者的影响。方法 选取该院 2016 年 4 月至2017 年 4 月收治的82例慢性肾脏病伴高尿酸血症患者进行分组比较,给予慢性肾脏病管理模式者纳入观察组,给予常规疾病管理者 纳入对照组,每组各 41 例。结果 干预后, 2 组尿酸水平均有所下降, 且观察组的尿酸水平显著低于对照组,差异有统计学意义 (P <0.05)。干预后,观察组的高嘌呤饮食者比例均显著低于对照组, 且观察组的运动者比例显著高于对照组, 差异有统计学意 义(P <0.05)。干预后观察组的肌酐、尿素氮及 24 h 尿蛋白定量与对照组相比具有明显改善,差异有统计学意义 (P <0.05)。结 论 临床将慢性肾脏病管理模式应用到慢性肾脏病伴高尿酸血症患者护理管理工作中, 可提升患者自我管理水平, 纠正不良生活 习惯,故有进一步推广的价值。 [ABSTRACT FROM AUTHOR]

Copyright of Chinese Journal of Clinical Healthcare is the property of Chinese Journal of Clinical Healthcare and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Objective To investigate the clinical effect of chronic disease management with traditional Chinese medicine (TCM) characteristics in community patients with chronic hepatitis B (CHB). Methods A non-randomized case-control study was performed for 84 CHB patients who visited Tianhe Community in Guangzhou from 2014 to 2016. These patients were divided into TCM chronic disease management group and control group, with 42 patients in each group. The patients in the TCM chronic disease management group were given oral entecavir tablets (0.5 mg, once a day) combined with TCM chronic disease management, and those in the control group were given entecavir tablets, education on disease knowledge, and instructions on medication. The two groups were compared in terms of alanine aminotransferase (ALT) normalization rate, HBeAg seroconversion rate, HBV DNA clearance rate, TCM symptom score, and quality-of-life score after 48 weeks of treatment. The two-independent-samples t test was used for comparison of normally distributed continuous data between groups, and the paired t-test was used for comparison before and after treatment; the non-parametric test was used for comparison of non-normally distributed continuous data between groups. The chi-square test was used for comparison of categorical data between groups, and the Fisher′s exact test was used when more than 20% of the cells have an expected frequency of less than 5. Results After 48 weeks of treatment, the TCM chronic disease management group had a significantly lower clinical syndrome score and a significantly higher overall quality-of-life score than the control group (clinical syndrome score: 3.66±1.92 vs 6.42±2.48, t=5.563, P＜0.001; overall quality-of-life score: 550.75±54.24 vs 491.08±54.21, t=-4.888, P＜0.001). Compared with the control group, the TCM chronic disease management group had slightly higher 48-week ALT normalization rate (80.00% vs 72.22%, χ2=0.590, P=0.443), HBV DNA clearance rate (73.17% vs 68.42%, P＞0.05), and HBeAg seroconversion rate (29.27% vs 18.42%, P＞0.05). Conclusion In community patients with CHB, chronic disease management with TCM characteristics can improve their clinical symptoms, quality of life, and antiviral outcome and thus holds promise for clinical application in community. [ABSTRACT FROM AUTHOR]

Objective To investigate the effectiveness of diabetes shared care model. Methods From October 2016 to June 2017, patients with diabetes mellitus who had been visiting shared care clinic for more than 6 months in Peking University First Hospital were selected. Height, weight and glycated hemoglobin A1c (HbA1c) level were measured at the first visit and 6-month follow-up. Five scales were used to evaluate its disease self-management ability and social psychology,“Summary of Diabetes Self Care Activities 6” “World Health Organization-5 Well-Being Index” “Patient Assessment of Chronic Illness Care-DAWN Short Form” (PACIC-DSF) “Diabetes Empowerment Scale-DAWN Short Form” and “Problem Areas in Diabetes Scale 5” (PAID-5). Results A total of 76 patients met the inclusion criteria and completed data collection and scale evaluation. Compared with baseline, scores of disease self-management ability in monitoring the blood sugar [1.0 (0.0, 3.0) vs 3.0 (1.0, 5.0) points, Z=2.978, P=0.003], and self-examination of the foot [0.0 (0.0, 6.8) vs 4.5 (1.0, 7.0) points, Z=3.374, P=0.001] were significantly improved after 6-month follow up, no significant difference was observed in healthy diet, exercise, or medication. Social psychology related index such as getting help from staff (PACIC-DSF) [(33±16) vs (41± 13), t=5.475, P<0.001] and low mood disorders (PAID-5) [43.4% (33/76) vs 48.7% (37/76), X2=11.023, P< 0.05] were significantly increased. No significant difference was found in authorization ability score and the happiness index. Patients achieved greater reduction in HbA1c (7.3%±1.4% vs 7.0%±1.2%, t=2.133, P< 0.05) six months later, with no significant difference in body mass index, low-density lipoprotein-cholesterol, and medication cost (all P>0.05). Conclusion Shared care model can improve blood glucose monitoring and foot self-examination ability, promote patients getting more help from healthcare professionals, alleviate mood disorders, and decrease HbA1c. [ABSTRACT FROM AUTHOR]

Chronic Hepatitis C is a global epidemic. and people with different sexes, ages, races, and nationalities are susceptible to hepatitis C virus ( HCV) infection. This article elaborates on the management method and individualized treatment regimens for special populations , including children with hepatitis C, patients with renal injury , patients undergoing liver transplantation, patients with liver cirrhosis, patients with HIV infection, and patients with acute hepatitis C. [ABSTRACT FROM AUTHOR]

Primary biliary cholangitis (PBC) is a disease with relatively strong heterogeneity, and different patients may have great differences in clinical process and phenotypes. Therefore, long - term treatment and follow - up are necessary for accurate risk stratification of these patients. Observation of clinical symptoms of PBC patients, measurement of the changes in related indices, and individualized management for each patient helps to provide standard treatment for low - risk PBC patients and bring benefits to high - risk patients through well -designed clinical studies. [ABSTRACT FROM AUTHOR]

Copyright of West China Journal of Stomatology is the property of Sichuan University, West China College of Stomatology and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Copyright of Chinese Journal of Clinical Healthcare is the property of Chinese Journal of Clinical Healthcare and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Copyright of Chinese Journal of Clinical Healthcare is the property of Chinese Journal of Clinical Healthcare and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Since the basis of liver disease and potential pathogenic factors for acute injury are different in Chinese and Western medicine, the diagnosis remains controversial. However, there is a consensus on the fact that the condition of ACLF can be reversed, and early diagnosis and reasonable treatment can improve prognosis. This article introduces the pathophysiology of ACLF from the aspects of risk factors, predisposing factors, response after injury, and organ failure and elaborates on the reasonable management measures to improve patients′ survival rate. [ABSTRACT FROM AUTHOR]